NCT06477302Recruiting
Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer
Construction and Psychometric Properties of the Therapeutic Adherence Scale for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC).
Source: ClinicalTrials.gov · Last updated 23 Dec 2025
Brief summary (registry, in English)
The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis. The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation? The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 281 (estimated)
- First submitted
- 21 Jun 2024
- Start date
- 23 Jun 2023
- Primary completion date
- 23 Jun 2026
- Lead sponsor
- Instituto Nacional de Cancerologia de Mexico
- Diseases
- Lung cancer
- NCT number
- NCT06477302
What you commit to
- Study type: Observational
- Planned participants: 281
- From 23 Jun 2023 to the primary completion date, 23 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe psychiatric conditions (schizophrenia or psychotic disorders) and/or addiction to any psychoactive substance (this will be identified as reported in the INCanet file).
Other
- Severe hearing or visual problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the clinical record file).
- Attentional or memory problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the INCanet file).
Who the study is looking for
- Patients diagnosed with lung cancer (SCLC and NSCLC).
- Over 18 years of age.
- Voluntary participation by understanding and accepting the informed consent letter.
- Patients undergoing Respiratory Rehabilitation treatment with one month assessment and follow-up.
- Patients in active medical treatment.
- Any clinical stage.
- Karnofsky Index ≥ 70.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Nacional de Cancerologia Coordinator of this site? Confirm its status | Mexico City | Mexico | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.